HONOLULU — No significant difference in treatment response was seen in patients given doxycycline or azithromycin to improve signs and symptoms of meibomian gland dysfunction, according to a poster presented here.
Vannarut Satitpitakul, MD, and colleagues conducted a prospective study to evaluate the associations between age, meibum secretion quality score and treatment response in patients with MGD.
In the study presented in a poster at the Association for Research in Vision and Ophthalmology, 155 patients with grade 3 or 4 MGD were randomly treated with either oral doxycycline 200 mg
Uncategorized